Invesco’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-69,026
Closed -$655K 3984
2018
Q2
$655K Buy
+69,026
New +$661K ﹤0.01% 3320
2018
Q1
Sell
-57,610
Closed -$574K 3819
2017
Q4
$574K Buy
+57,610
New +$630K ﹤0.01% 3249
2015
Q3
Sell
-14,368
Closed -$89K 4171
2015
Q2
$89K Sell
14,368
-1,626
-10% -$9.98K ﹤0.01% 3879
2015
Q1
$82K Buy
15,994
+1,057
+7% +$5.2K ﹤0.01% 3820
2014
Q4
$68K Sell
14,937
-1,502
-9% -$7.13K ﹤0.01% 3866
2014
Q3
$80K Sell
16,439
-21,710
-57% -$105K ﹤0.01% 3898
2014
Q2
$211K Sell
38,149
-1,782
-4% -$8K ﹤0.01% 3677
2014
Q1
$160K Buy
39,931
+5,651
+16% +$23K ﹤0.01% 3838
2013
Q4
$137K Buy
+34,280
New +$137K ﹤0.01% 3944

Other funds holding CO

Invesco's CO Position: Q3 2018 in Review

Invesco sold out of Global Cord Blood Corporation (CO) in Q3 2018, closing a stake of 69,026 shares — an estimated $655K sold.

Invesco first reported a position in CO in Q4 2013 and held it in 9 quarters. The position peaked at $655K in Q2 2018. 43 funds tracked by Wall St. Rank hold CO as of Q3 2018.

  • Invesco reported no remaining Global Cord Blood Corporation position as of Q3 2018 after selling out during the quarter.
  • Invesco sold 69,026 Global Cord Blood Corporation shares in Q3 2018, an estimated $655K.
  • Invesco first reported a position in Global Cord Blood Corporation in Q4 2013 and held it in 9 quarters.
  • Invesco's Global Cord Blood Corporation position peaked at $655K in Q2 2018.
  • 43 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2018.

Based on Invesco's 13F filing for Q3 2018, filed 14 Nov 2018.